BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) Fundamental Analysis & Valuation

NYSE:BKDT • US1124633025

Current stock price

77.6 USD
-2.09 (-2.62%)
Last:

This BKDT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BKDT Profitability Analysis

1.1 Basic Checks

  • BKDT had negative earnings in the past year.
  • In the past year BKDT had a positive cash flow from operations.
  • BKDT had negative earnings in 4 of the past 5 years.
  • Of the past 5 years BKDT 4 years had a positive operating cash flow.
BKDT Yearly Net Income VS EBIT VS OCF VS FCFBKDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -3.19%, BKDT is in line with its industry, outperforming 42.73% of the companies in the same industry.
  • The Return On Equity of BKDT (-95.04%) is worse than 76.36% of its industry peers.
  • BKDT's Return On Invested Capital of 0.76% is in line compared to the rest of the industry. BKDT outperforms 42.73% of its industry peers.
Industry RankSector Rank
ROA -3.19%
ROE -95.04%
ROIC 0.76%
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
BKDT Yearly ROA, ROE, ROICBKDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • The Operating Margin of BKDT (1.76%) is comparable to the rest of the industry.
  • BKDT's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 25.57%, BKDT perfoms like the industry average, outperforming 50.91% of the companies in the same industry.
  • BKDT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.76%
PM (TTM) N/A
GM 25.57%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
BKDT Yearly Profit, Operating, Gross MarginsBKDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

0

2. BKDT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BKDT is destroying value.
  • The number of shares outstanding for BKDT has been increased compared to 1 year ago.
  • The number of shares outstanding for BKDT has been increased compared to 5 years ago.
  • Compared to 1 year ago, BKDT has an improved debt to assets ratio.
BKDT Yearly Shares OutstandingBKDT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BKDT Yearly Total Debt VS Total AssetsBKDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • BKDT has an Altman-Z score of 1.14. This is a bad value and indicates that BKDT is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.14, BKDT is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
  • BKDT has a Debt/Equity ratio of 20.19. This is a high value indicating a heavy dependency on external financing.
  • BKDT has a worse Debt to Equity ratio (20.19) than 84.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 20.19
Debt/FCF N/A
Altman-Z 1.14
ROIC/WACC0.09
WACC8.64%
BKDT Yearly LT Debt VS Equity VS FCFBKDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

  • A Current Ratio of 0.88 indicates that BKDT may have some problems paying its short term obligations.
  • BKDT has a worse Current ratio (0.88) than 78.18% of its industry peers.
  • BKDT has a Quick Ratio of 0.88. This is a bad value and indicates that BKDT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.88, BKDT is doing worse than 70.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
BKDT Yearly Current Assets VS Current LiabilitesBKDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. BKDT Growth Analysis

3.1 Past

  • The earnings per share for BKDT have decreased by -5.95% in the last year.
  • BKDT shows a small growth in Revenue. In the last year, the Revenue has grown by 3.63%.
  • BKDT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.08% yearly.
EPS 1Y (TTM)-5.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.5%
Revenue 1Y (TTM)3.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.51%

3.2 Future

  • Based on estimates for the next years, BKDT will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.13% on average per year.
  • The Revenue is expected to grow by 2.10% on average over the next years.
EPS Next Y34.18%
EPS Next 2Y19.37%
EPS Next 3Y18.13%
EPS Next 5YN/A
Revenue Next Year2.75%
Revenue Next 2Y-0.46%
Revenue Next 3Y2.1%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BKDT Yearly Revenue VS EstimatesBKDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
BKDT Yearly EPS VS EstimatesBKDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

1

4. BKDT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BKDT. In the last year negative earnings were reported.
  • Also next year BKDT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKDT Price Earnings VS Forward Price EarningsBKDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as BKDT.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 46.27
BKDT Per share dataBKDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BKDT's earnings are expected to grow with 18.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.37%
EPS Next 3Y18.13%

5

5. BKDT Dividend Analysis

5.1 Amount

  • BKDT has a Yearly Dividend Yield of 4.51%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.47, BKDT pays a better dividend. On top of this BKDT pays more dividend than 97.27% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, BKDT pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.51%

5.2 History

  • BKDT has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BKDT Yearly Dividends per shareBKDT Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 1 2 3

5.3 Sustainability

DPN/A
EPS Next 2Y19.37%
EPS Next 3Y18.13%
BKDT Yearly Income VS Free CF VS DividendBKDT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

BKDT Fundamentals: All Metrics, Ratios and Statistics

BROOKDALE SENIOR LIVING - BKD 7 11/15/25

NYSE:BKDT (3/27/2025, 8:04:01 PM)

77.6

-2.09 (-2.62%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-18
Earnings (Next)05-05
Inst Owners106.89%
Inst Owner ChangeN/A
Ins Owners3.68%
Ins Owner ChangeN/A
Market Cap15.53B
Revenue(TTM)3.13B
Net Income(TTM)-201.94M
Analysts73.33
Price Target105.12 (35.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.51%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.06%
Min EPS beat(2)-74.45%
Max EPS beat(2)-25.67%
EPS beat(4)1
Avg EPS beat(4)-21.47%
Min EPS beat(4)-74.45%
Max EPS beat(4)26.45%
EPS beat(8)3
Avg EPS beat(8)-5.89%
EPS beat(12)4
Avg EPS beat(12)-2.98%
EPS beat(16)7
Avg EPS beat(16)16.88%
Revenue beat(2)0
Avg Revenue beat(2)-1.05%
Min Revenue beat(2)-1.1%
Max Revenue beat(2)-1%
Revenue beat(4)0
Avg Revenue beat(4)-1.09%
Min Revenue beat(4)-1.2%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-0.88%
Revenue beat(12)0
Avg Revenue beat(12)-0.72%
Revenue beat(16)0
Avg Revenue beat(16)-1.27%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)10.25%
EPS NQ rev (3m)22.22%
EPS NY rev (1m)8.42%
EPS NY rev (3m)8.42%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.97
P/FCF N/A
P/OCF 93.48
P/B 73.11
P/tB 83.9
EV/EBITDA 46.27
EPS(TTM)-0.89
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)0.83
OCFY1.07%
SpS15.61
BVpS1.06
TBVpS0.92
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -3.19%
ROE -95.04%
ROCE 0.96%
ROIC 0.76%
ROICexc 0.8%
ROICexgc 0.81%
OM 1.76%
PM (TTM) N/A
GM 25.57%
FCFM N/A
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 20.19
Debt/FCF N/A
Debt/EBITDA 10.15
Cap/Depr 84.26%
Cap/Sales 9.91%
Interest Coverage 0.23
Cash Conversion 39.32%
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z 1.14
F-Score6
WACC8.64%
ROIC/WACC0.09
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.5%
EPS Next Y34.18%
EPS Next 2Y19.37%
EPS Next 3Y18.13%
EPS Next 5YN/A
Revenue 1Y (TTM)3.63%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.51%
Revenue Next Year2.75%
Revenue Next 2Y-0.46%
Revenue Next 3Y2.1%
Revenue Next 5YN/A
EBIT growth 1Y142.36%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year517.25%
EBIT Next 3Y97.55%
EBIT Next 5YN/A
FCF growth 1Y-102.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2%
OCF growth 3YN/A
OCF growth 5Y-5.14%

BROOKDALE SENIOR LIVING - BKD 7 11/15/25 / BKDT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BROOKDALE SENIOR LIVING - BKD 7 11/15/25?

ChartMill assigns a fundamental rating of 2 / 10 to BKDT.


What is the valuation status for BKDT stock?

ChartMill assigns a valuation rating of 1 / 10 to BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT). This can be considered as Overvalued.


How profitable is BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) stock?

BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) has a profitability rating of 3 / 10.


What is the earnings growth outlook for BROOKDALE SENIOR LIVING - BKD 7 11/15/25?

The Earnings per Share (EPS) of BROOKDALE SENIOR LIVING - BKD 7 11/15/25 (BKDT) is expected to grow by 34.18% in the next year.